Bryan Garnier

Eric Le Berrigaud

email

Gilbert Dupont

Jamila El Bougrini

email

Goldman Sachs

Graig Suvannavejh

email

H.C. Wainwright & Co.

Swayampakula Ramakanth, Ph.D.

email

Invest Securities

 

 

Leerink Jonathan Chang email

Oddo Securities

Pierre Corby

email

Portzamparc

Christophe Dombu

Pierre-Alexandre D├ęsir

email

email

The opinions, assessments or forecasts from these analysts on Innate Pharma performance levels and activities are not necessarily representative of Innate Pharma's ownforecasts, nor are they necessarily shared by its management.